{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T08:48:37Z","timestamp":1782031717135,"version":"3.54.5"},"reference-count":64,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007914","name":"University of Texas Southwestern Medical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007914","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ijrobp.2026.02.195","type":"journal-article","created":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T15:54:48Z","timestamp":1770479688000},"page":"44-55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Adaptive MRI-Guided Reirradiation for High-Risk Recurrent Grade 4 Gliomas: Early Clinical Outcomes and Volumetric Response"],"prefix":"10.1016","volume":"125","author":[{"given":"Luiza Giuliani","family":"Schmitt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Dohopolski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill","family":"de Vis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomaz Rodrigues","family":"Mostardeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas Pari","family":"Mitre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Youssef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan","family":"Noch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Maher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toral","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankur","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MinJae","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktor","family":"Iakovenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuicheng","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan-Chi","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnold","family":"Pompos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mu-Han","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Timmerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tu","family":"Dan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9007-8415","authenticated-orcid":false,"given":"Zabi","family":"Wardak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2026.02.195_bib0001","first-page":"896","article-title":"The epidemiology of glioma in adults: A \u201cstate of the science\u201d review","volume":"16","author":"Ostrom","year":"2014","journal-title":"Neurooncology"},{"key":"10.1016\/j.ijrobp.2026.02.195_bib0002","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1200\/JCO.22.01785","article-title":"Reirradiation for recurrent glioblastoma: What we know and what we do not","volume":"41","author":"Knisely","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.195_bib0003","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1001\/jamaoncol.2022.2844","article-title":"World Health Organization 2021 classification of central nervous system tumors and implications for therapy for adult-type gliomas: A review","volume":"8","author":"Berger","year":"2022","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.195_bib0004","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1056\/NEJMoa0808710","article-title":"IDH1 and IDH2 mutations in gliomas","volume":"360","author":"Yan","year":"2009","journal-title":"New Engl J Med"},{"key":"10.1016\/j.ijrobp.2026.02.195_bib0005","article-title":"Treatment options for progression or recurrence of glioblastoma: A network meta-analysis","volume":"5","author":"McBain","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ijrobp.2026.02.195_bib0006","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1200\/JCO.22.00164","article-title":"NRG Oncology\/RTOG1205: A randomized phase II trial of concurrent bevacizumab and reirradiation versus bevacizumab alone as treatment for recurrent glioblastoma","volume":"41","author":"Tsien","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.195_bib0007","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.radonc.2019.06.009","article-title":"Bevacizumab reduces toxicity of reirradiation in recurrent high-grade glioma","volume":"138","author":"Fleischmann","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.195_bib0008","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.prro.2016.03.007","article-title":"Radiation therapy for glioblastoma: Executive summary of an American Society for Radiation Oncology evidence-based clinical practice guideline","volume":"6","author":"Cabrera","year":"2016","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.195_bib0009","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ijrobp.2017.08.038","article-title":"Investigating the effect of reirradiation or systemic therapy in patients with glioblastoma after tumor progression: A secondary analysis of NRG Oncology\/Radiation Therapy Oncology Group Trial 0525","volume":"100","author":"Shi","year":"2018","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.195_bib0010","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s11060-017-2564-z","article-title":"Treatment outcome of patients with recurrent glioblastoma multiforme: A retrospective multicenter analysis","volume":"135","author":"Van Linde","year":"2017","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ijrobp.2026.02.195_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2023.107728","article-title":"Fractionated stereotactic re-irradiation for recurrent glioblastoma: A systematic review and meta-analysis","volume":"229","author":"Luo","year":"2023","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.ijrobp.2026.02.195_bib0012","article-title":"Differential predictors and clinical implications associated with long-term survivors in IDH wildtype and mutant glioblastoma","volume":"11","author":"Jiang","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.195_bib0013","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.577443","article-title":"Salvage radiation therapy for patients with relapsing glioblastoma multiforme and the role of slow fractionation","volume":"10","author":"Ciernik","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.195_bib0014","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s11060-018-03064-0","article-title":"Re-irradiation for recurrent glioblastoma (GBM): A systematic review and meta-analysis","volume":"142","author":"Kazmi","year":"2010","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ijrobp.2026.02.195_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110437","article-title":"Re-irradiation treatment regimens for patients with recurrent glioma\u2014Evaluation of the optimal dose and best concurrent therapy","volume":"199","author":"Fleischmann","year":"2024","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.ijrobp.2026.02.195_bib0016","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s11060-023-04340-4","article-title":"Re-irradiation for recurrent high-grade glioma: An analysis of prognostic factors for survival and predictors of radiation necrosis","volume":"163","author":"Moore-Palhares","year":"2023","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ijrobp.2026.02.195_bib0017","doi-asserted-by":"crossref","first-page":"3652","DOI":"10.3390\/cancers16213652","article-title":"Efficacy and low toxicity of normo-fractionated re-irradiation with combined chemotherapy for recurrent glioblastoma\u2014An analysis of treatment response and failure","volume":"16","author":"Pepper","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.ijrobp.2026.02.195_bib0018","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s11060-024-04643-0","article-title":"Hypofractionated re-irradiation with bevacizumab for relapsed chemorefractory glioblastoma after prior high dose radiotherapy: A feasible option for patients with large-volume relapse","volume":"168","author":"Tong","year":"2024","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ijrobp.2026.02.195_bib0019","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13014-021-01767-9","article-title":"Current status and recent advances in reirradiation of glioblastoma","volume":"16","author":"Minniti","year":"2021","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.195_bib0020","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20160667","article-title":"The future of image-guided radiotherapy will be MR guided","volume":"90","author":"Pollard","year":"2017","journal-title":"The Br J Radiol"},{"key":"10.1016\/j.ijrobp.2026.02.195_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109947","article-title":"Re-irradiation in clinical practice: Results of an international patterns of care survey within the framework of the ESTRO-EORTC E2-radiate platform","volume":"189","author":"Willmann","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.195_bib0022","first-page":"S3","article-title":"Evolving concepts in margin strategies and adaptive radiotherapy for glioblastoma: A new future is on the horizon","volume":"26","author":"Tseng","year":"2024","journal-title":"Neurooncology"},{"key":"10.1016\/j.ijrobp.2026.02.195_bib0023","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.ijrobp.2020.10.002","article-title":"Quantitating interfraction target dynamics during concurrent chemoradiation for glioblastoma: A prospective serial imaging study","volume":"109","author":"Stewart","year":"2021","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.195_bib0024","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3389\/fonc.2015.00106","article-title":"Salvage fractionated stereotactic radiotherapy with or without chemotherapy and immunotherapy for recurrent glioblastoma multiforme: A single institution experience","volume":"5","author":"Hasan","year":"2015","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.195_bib0025","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s11060-023-04407-2","article-title":"The evolving role of reirradiation in the management of recurrent brain tumors","volume":"164","author":"De Pietro","year":"2023","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ijrobp.2026.02.195_bib0026","unstructured":"ClinicalTrials.gov. Simulated adaptive radiotherapy for shrinking glioblastoma resection cavities on a hybrid MRI\u2013linear accelerator (UNITED) [NCT04726397]; 2023. Accessed June 11, 2025. https:\/\/clinicaltrials.gov\/study\/NCT04726397"},{"key":"10.1016\/j.ijrobp.2026.02.195_bib0027","unstructured":"ClinicalTrials.gov. UNITy-BasED MR-Linac adaptive simultaneous integrated hypofractionationed boost trial for high grade glioma in the elderly (UNITED2) [NCT05565521]; 2023. Accessed June 11, 2025. https:\/\/clinicaltrials.gov\/study\/NCT05565521"},{"key":"10.1016\/j.ijrobp.2026.02.195_bib0028","unstructured":"ClinicalTrials.gov. UNIty-based MR-Linac guided adaptive RadioThErapy for high GraDe Glioma-3 (UNITED-3) [NCT05720078]; 2023. Accessed June 11, 2025. https:\/\/clinicaltrials.gov\/study\/NCT05720078"},{"key":"10.1016\/j.ijrobp.2026.02.195_bib0029","doi-asserted-by":"crossref","first-page":"101813","DOI":"10.1016\/j.adro.2025.101813","article-title":"Comparative outcomes of standard radiotherapy and 5-fraction adaptive stereotactic radiation therapy in newly diagnosed glioblastoma: A propensity score-matched analysis","volume":"20","author":"Dohopolski","year":"2025","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.195_bib0030","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.ijrobp.2021.03.047","article-title":"Personalized ultrafractionated stereotactic adaptive radiotherapy (PULSAR) in preclinical models enhances single-agent immune checkpoint blockade","volume":"110","author":"Moore","year":"2021","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.195_bib0031","doi-asserted-by":"crossref","first-page":"1357790","DOI":"10.3389\/fonc.2024.1357790","article-title":"Rethinking the potential role of dose painting in personalized ultra-fractionated stereotactic adaptive radiotherapy","volume":"14","author":"Peng","year":"2024","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.195_bib0032","article-title":"Exploratory evaluation of personalized ultrafractionated stereotactic adaptive radiation therapy (PULSAR) with central nervous system-active drugs in brain metastases treatment","volume":"S03603011624036411","author":"Dohopolski","year":"2024","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.195_bib0033","doi-asserted-by":"crossref","first-page":"e469","DOI":"10.1016\/S1470-2045(22)00447-8","article-title":"European Society for Radiotherapy and Oncology and European Organisation for research and treatment of cancer consensus on re-irradiation: Definition, reporting, and clinical decision making","volume":"23","author":"Andratschke","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.195_bib0034","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1200\/JCO.2008.19.4969","article-title":"Recurrence pattern after temozolomide concomitant with and adjuvant to radiotherapy in newly diagnosed patients with glioblastoma: Correlation with MGMT promoter methylation status","volume":"27","author":"Brandes","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.195_bib0035","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1186\/s12885-021-08467-3","article-title":"Limited recurrence distance of glioblastoma under modern radiotherapy era","volume":"21","author":"Tu","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ijrobp.2026.02.195_bib0036","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/1748-717X-9-130","article-title":"Patterns of failure for glioblastoma multiforme following limited-margin radiation and concurrent temozolomide","volume":"9","author":"Gebhardt","year":"2014","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.195_bib0037","first-page":"86","article-title":"Impact of volume of irradiation on survival and quality of life in glioblastoma: A prospective, phase 2, randomized comparison of RTOG and MDACC protocols","volume":"7","author":"Kumar","year":"2020","journal-title":"Neurooncol Pract"},{"key":"10.1016\/j.ijrobp.2026.02.195_bib0038","doi-asserted-by":"crossref","first-page":"5187","DOI":"10.1200\/JCO.23.01059","article-title":"Rano 2.0: Update to the response assessment in neuro-oncology criteria for high- and low-grade gliomas in adults","volume":"41","author":"Wen","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.195_bib0039","article-title":"The patterns of failure and prognostic impact of tumor location in patients undergoing reirradiation for glioblastoma","volume":"16","author":"Reinders","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.ijrobp.2026.02.195_bib0040","article-title":"Re-irradiation of recurrent IDH-wildtype glioblastoma in the bevacizumab and immunotherapy era: Target delineation, outcomes and patterns of recurrence","volume":"44","author":"Christ","year":"2023","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.195_bib0041","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.ijrobp.2024.01.013","article-title":"Prospective randomized phase 2 trial of hypofractionated stereotactic radiation therapy of 25 Gy in 5 fractions compared with 35 Gy in 5 fractions in the reirradiation of recurrent glioblastoma","volume":"119","author":"Chen","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.02.195_bib0042","doi-asserted-by":"crossref","first-page":"29","DOI":"10.14791\/btrt.2020.8.e10","article-title":"Re-irradiation and its contribution to good prognosis in recurrent glioblastoma patients","volume":"8","author":"Kim","year":"2020","journal-title":"Brain Tumor Res Treat"},{"key":"10.1016\/j.ijrobp.2026.02.195_bib0043","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.radonc.2021.12.019","article-title":"Re-irradiation for recurrent high grade glioma (HGG) patients: Results of a single-arm prospective phase 2 study","volume":"167","author":"Navarria","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.195_bib0044","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/ajco.13457","article-title":"Clinical characterization of glioblastoma patients living longer than 2 years: A retrospective analysis of two Italian institutions","volume":"17","author":"Anselmo","year":"2021","journal-title":"Asia Pac J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.195_bib0045","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1093\/oncolo\/oyad095","article-title":"Hypofractionated stereotactic re-irradiation and anti-PDL1 durvalumab combination in recurrent glioblastoma: STERIMGLI phase I results","volume":"28","author":"Pouessel","year":"2023","journal-title":"Oncologist"},{"key":"10.1016\/j.ijrobp.2026.02.195_bib0046","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jocn.2020.01.086","article-title":"Patterns of management and outcomes of unifocal versus multifocal glioblastoma","volume":"74","author":"Haque","year":"2020","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.ijrobp.2026.02.195_bib0047","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jocn.2020.11.025","article-title":"A systematic review of multifocal and multicentric glioblastoma","volume":"83","author":"Li","year":"2021","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.ijrobp.2026.02.195_bib0048","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1200\/JCO.2009.21.9832","article-title":"Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas","volume":"27","author":"Sanson","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.195_bib0049","article-title":"Prognostic differences and implications on treatment strategies between butterfly glioblastoma and glioblastoma with unilateral corpus callosum infiltration","volume":"12","author":"Hazaymeh","year":"2022","journal-title":"Sci Reports"},{"key":"10.1016\/j.ijrobp.2026.02.195_bib0050","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s11060-014-1597-9","article-title":"The butterfly effect on glioblastoma: Is volumetric extent of resection more effective than biopsy for these tumors?","volume":"120","author":"Chaichana","year":"2014","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ijrobp.2026.02.195_bib0051","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1200\/JCO.2010.30.0582","article-title":"Scale to predict survival after surgery for recurrent glioblastoma multiforme","volume":"28","author":"Park","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.195_bib0052","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.21873\/anticanres.17119","article-title":"Prognostic factors for progression-free survival and overall survival after recurrence of glioblastoma","volume":"44","author":"Zemskova","year":"2024","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ijrobp.2026.02.195_bib0053","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.ejca.2012.02.004","article-title":"New prognostic factors and calculators for outcome prediction in patients with recurrent glioblastoma: A pooled analysis of EORTC brain tumour group phase I and II clinical trials","volume":"48","author":"Gorlia","year":"2021","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2026.02.195_bib0054","doi-asserted-by":"crossref","first-page":"802","DOI":"10.3171\/2014.6.JNS132038","article-title":"Residual tumor volume and patient survival following reoperation for recurrent glioblastoma: Clinical article","volume":"121","author":"Yong","year":"2014","journal-title":"J Neurosurg"},{"key":"10.1016\/j.ijrobp.2026.02.195_bib0055","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s11060-025-05058-1","article-title":"Current trends in reoperation for recurrent glioblastoma: A meta-analysis (2007-2023)","volume":"174","author":"Pichardo-Rojas","year":"2025","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ijrobp.2026.02.195_bib0056","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.wneu.2018.04.016","article-title":"The survival effect of repeat surgery at glioblastoma recurrence and its trend: A systematic review and meta-analysis","volume":"115","author":"Lu","year":"2018","journal-title":"World Neurosurg"},{"key":"10.1016\/j.ijrobp.2026.02.195_bib0057","article-title":"Impact of reirradiation utilizing fractionated stereotactic radiotherapy for recurrent glioblastoma","volume":"16","author":"Shields","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.ijrobp.2026.02.195_bib0058","first-page":"vdaf004","article-title":"Fractionated reirradiation of recurrent high-grade gliomas: Safety with higher reirradiation dose and larger targets","volume":"7","author":"LeCompte","year":"2025","journal-title":"Neurooncol Adv"},{"key":"10.1016\/j.ijrobp.2026.02.195_bib0059","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s00066-020-01585-0","article-title":"Re-irradiation for recurrent glioblastoma multiforme: A critical comparison of different concepts","volume":"196","author":"Baehr","year":"2020","journal-title":"Strahlenther. Onkol."},{"key":"10.1016\/j.ijrobp.2026.02.195_bib0060","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2024.42.16_suppl.2063","article-title":"Multi-institutional study of reirradiation for recurrent high grade glioma","volume":"42","author":"Helis","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.195_bib0061","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1060098","article-title":"High grade glioma radiation therapy on a high field 1.5 tesla MR-Linac\u2014workflow and initial experience with daily adapt-to-position (ATP) MR guidance: A first report","volume":"12","author":"Tseng","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.195_bib0062","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.meddos.2023.02.001","article-title":"Treatment of glioblastoma using MRIdian\u00ae A3i BrainTx\u2122: Imaging and treatment workflow demonstration","volume":"48","author":"La Rosa","year":"2023","journal-title":"Med Dosim"},{"key":"10.1016\/j.ijrobp.2026.02.195_bib0063","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.3390\/cancers15051555","article-title":"Simulated adaptive radiotherapy for shrinking glioblastoma resection cavities on a hybrid MRI\u2013linear accelerator","volume":"15","author":"Guevara","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.ijrobp.2026.02.195_bib0064","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1186\/s12883-024-03954-z","article-title":"Re-irradiation for recurrent glioblastoma: A pattern of care analysis","volume":"24","author":"Rogers","year":"2024","journal-title":"BMC Neurol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301626003299?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301626003299?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T08:31:28Z","timestamp":1782030688000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301626003299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0360301626003299"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2026.02.195","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adaptive MRI-Guided Reirradiation for High-Risk Recurrent Grade 4 Gliomas: Early Clinical Outcomes and Volumetric Response","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2026.02.195","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}